Wound Debridement Market Analysis

The market is segmented based on product into gel and ointment, medical debridement pads, medical gauzes, enzymatic debridement products and, others, out of which, the gels segment is anticipated to grab the largest share by the end of 2021 as gels are having property to avoid enzymatic activity and drug interaction with food and drinks. In addition, no inflammation, less bleeding, removal of necrotic tissue safely and without infection are some factors that are contributing to the growth of this segment.

On the basis of application, diabetic foot ulcers are observed as the fastest growing segment due to increasing prevalence of diabetes. Furthermore, pressure ulcers are anticipated to hold the largest share in the market in owing to increasing incidence of bedsores. In addition, skin of aged people is highly sensitive and is more prone towards developing bedsores, thereby bolstering the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

By Therapy Type	Gel and ointment Medical debridement pads Medical gauzes Enzymatic debridement products Others
By Wound Type	Diabetic foot ulcers Pressure ulcers Burns Others

Frequently Asked Questions (FAQ)

Growing incidence of pressure ulcers, diabetic foot and surgical procedures and rise in the incidence of wound infections are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

High cost of treatment are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the improving healthcare infrastructure and facilities.

The major players dominating the wound debridement market are Smith & Nephew, B. Braun Melsungen AG, Zimmer Biomet, Misonix, MediWound among others.

Wound Debridement Market Analysis